5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.83▲ | 10.03▼ | 10.02▼ | 9.85▼ | 9.71▲ |
MA10 | 10.01▼ | 10.26▼ | 10.04▼ | 9.89▼ | 7.90▲ |
MA20 | 10.09▼ | 9.96▼ | 9.87▼ | 9.07▲ | 6.57▲ |
MA50 | 9.97▼ | 9.86▼ | 9.92▼ | 6.86▲ | 6.64▲ |
MA100 | 9.80▲ | 9.91▼ | 9.65▲ | 6.12▲ | 22.81▼ |
MA200 | 9.86▼ | 9.36▲ | 8.02▲ | 4.55▲ | 29.64▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.063▼ | -0.030▼ | 0.012▲ | -0.060▼ | 0.855▲ |
RSI | 40.202▼ | 47.171▼ | 48.846▼ | 63.204▲ | 62.543▲ |
STOCH | 11.739▼ | 29.318 | 56.025 | 52.377 | 88.481▲ |
WILL %R | -78.302▼ | -82.938▼ | -59.727 | -44.898 | -14.765▲ |
CCI | -105.234▼ | -85.292 | -15.719 | 58.756 | 108.984▲ |
Friday, June 13, 2025 04:30 AM
Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation ...
|
Wednesday, June 11, 2025 05:00 PM
LAS VEGAS, NV / ACCESSWIRE / January 10, 2025 / Alyea Therapeutics Corporation Inc. ("Alyea" or the "Company"), a subsidiary of Alt 5 Sigma Corporation (NASDAQ:ALTS), announced today its ...
|
Wednesday, June 11, 2025 01:09 PM
LAS VEGAS, NV / ACCESS Newswire / June 11, 2025 / ALT5 Sigma Corporation (NASDAQ:ALTS)(FRA:5AR1), a fintech specializing in turnkey, crypto-related solutions for institutions and merchants, is pleased ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 10.24 | 10.27 | 9.735 | 9.85 | 80,509 |
13/06/25 | 9.19 | 10.80 | 9.19 | 10.26 | 305,700 |
12/06/25 | 9.52 | 10.22 | 9.15 | 9.57 | 342,900 |
11/06/25 | 9.90 | 10.18 | 9.45 | 9.74 | 184,600 |
10/06/25 | 10.325 | 10.325 | 9.75 | 9.83 | 152,381 |
09/06/25 | 10.21 | 10.64 | 9.50 | 9.93 | 265,750 |
06/06/25 | 9.98 | 10.95 | 9.56 | 10.21 | 333,600 |
05/06/25 | 9.66 | 10.18 | 9.14 | 9.735 | 189,831 |
04/06/25 | 10.04 | 10.10 | 9.68 | 9.73 | 173,929 |
03/06/25 | 8.99 | 10.09 | 8.55 | 10.08 | 346,213 |
|
|
||||
|
|
||||
|
|